RSC Biomolecular Sciences
Structure-Based Drug Discovery
An Overview
-
DOI: 10.1039/9781847552549
Roderick E Hubbard (Editor)
ISBN (online): 978-1-84755-254-9
ISBN (print): 978-0-85404-351-4
Copyright: 2006
Table of Contents
| Title | Page | |
 Front matter
DOI: 10.1039/9781847552549-FP001 (67Kb) |
Full Access | |
|
Preface
DOI: 10.1039/9781847552549-FP005 (28Kb) |
Full Access | |
|
Acknowledgements
DOI: 10.1039/9781847552549-FP009 (18Kb) |
Full Access | |
|
Contents
DOI: 10.1039/9781847552549-FP011 (43Kb) |
Full Access | |
|
3D Structure and the Drug Discovery Process
DOI: 10.1039/9781847552549-00001 (151Kb) |
1 | Full Access |
| Structure Determination - Crystallography for Structure-Based Drug Discovery | 32 | License Access |
| Molecular Modelling | 54 | License Access |
| Applications of NMR in Structure-Based Drug Discovery | 97 | License Access |
| Fragment Screening: An Introduction | 142 | License Access |
| Iterative Structure-Based Screening of Virtual Chemical Libraries and Factor Xa: Finding the Orally Available Antithrombotic Candidate LY517717 | 173 | License Access |
| Anti-Influenza Drugs from Neuraminidase Inhibitors | 193 | License Access |
| Isoform Specificity: The Design of Estrogen Receptor-ß Selective Compounds | 219 | License Access |
| Subject Index | 257 | License Access |
